Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis

BACKGROUND: An objective of the Severe Heterogeneous Asthma Registry, Patient-centered (SHARP) is to produce real-world evidence on a pan-European scale by linking nonstandardised, patient-level registry data. Mepolizumab has shown clinical efficacy in randomised controlled trials and prospective re...

Descripción completa

Detalles Bibliográficos
Autores principales: Kroes, Johannes A., Alfonso-Cristancho, Rafael, Bansal, Aruna T., Berret, Emmanuelle, Bieksiene, Kristina, Bourdin, Arnaud, Brussino, Luisa, Canhoto, Diogo, Cardini, Cristina, Celik, Gulfem, Csoma, Zsuzsanna, Dahlén, Barbro, Damadoglu, Ebru, Eger, Katrien, Gauquelin, Lisa, Gemicioglu, Bilun, Goksel, Ozlem, Graff, Sophie, Heffler, Enrico, Hofstee, Hendrik B., Howarth, Peter, Jakes, Rupert W., Jaun, Fabienne, Kalinauskaite-Zukauske, Virginija, Kopač, Peter, Kwon, Namhee, Loureiro, Claudia C., Lozoya García, Victor, Masoli, Matthew, Rezelj, Mariana Paula, Pérez De Llano, Luis, Popović-Grle, Sanja, Ramos-Barbón, David, Sà Sousa, Ana, Samitas, Konstantinos, Schleich, Florence, Sirena, Concetta, Skrgat, Sabina, Zervas, Eleftherios, Zichnalis, George, Bel, Elisabeth H., Sont, Jacob K., Hashimoto, Simone, Ten Brinke, Anneke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068512/
https://www.ncbi.nlm.nih.gov/pubmed/37020841
http://dx.doi.org/10.1183/23120541.00745-2022

Ejemplares similares

Ejemplares similares